Stock Talk Cannabis Report image of cannabis plants and VW van
(Source: File)

Lifeist Wellness’ chairman wrote a letter to shareholders explaining the reasoning behind the decision to divest the company of CannMart Inc. via a sale to Simply Solventless Concentrates Ltd. He said the regulatory framework under which Canadian public cannabis companies operate has proven to be prohibitively expensive for all public companies in the space in terms of ever being able to turn a profit.

(File photo.)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | PharmaDrug’s Sairiyo Therapuetics provides plans to advance PD-001 (patented reformulated cepharanthine) for viral infectious diseases

2 | Avicanna secures U.S. patent and trademark on topical technology

3 | Canopy Growth’s Wana Brands launches first-of-its-kind marketplace

Top Cannabis Stocks Aug. 23 to Aug. 29, 2024

1. T.TLRY | 10,355 views | Tilray Brands Inc.
2. T.WEED | 4,454 views | Canopy Growth Corp
3. C.CURA | 4,432 views | Curaleaf Holdings Inc.
4. T.LABS | 1,818 views | Medipharm Labs Corp.
5. C.OILS | 1,645 views | Nextleaf Solutions Ltd.
6. C.PHRX | 899 views | Pharmadrug Inc.


The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.


More From The Market Online
Air Canada airliner

Air Canada negotiates new labour deal with pilots, avoids shutdown

Air Canada (TSX:AC) and the union representing thousands of its pilots negotiated a new labour deal and averted a nationwide shutdown.
Tudor Gold 2020 drilling at Treaty Creek.

Tudor Gold to advance Treaty Creek Project with Fuse Advisors

Tudor Gold (TSXV:TUD) enters into an agreement with Fuse Advisors to advance the Treaty Creek Project in British Columbia's Golden Triangle.
U.S. Food and Drug website in browser with logo

FDA extends review period for Medexus’ treosulfan to 2025

Medexus Pharmaceuticals (TSX:MDP) reveals the U.S. FDA has extended the review period for the company's new drug application for treosulfan.
King's Cross station in London

AtkinsRéalis boosts long-term revenue with U.K. rail contract

AtkinsRéalis Group (TSX:ATRL) will modernize the U.K.'s rail signalling infrastructure over the next decade.